Recent

% | $
Quotes you view appear here for quick access.

Bristol-Myers Squibb Company Message Board

  • poorhah poorhah Nov 30, 2009 5:25 PM Flag

    Exchange-Bmy for Mjn

    How do you Bmy or Mjn stock holders feel about this exchange???

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • so how many mistakes have the BMY management made over the past yrs? all of these fools who think BMY is still a takeover candidate MRK, PFE have all passed on it. now they think they can remake themselves into a new co i highly doubt they have what it takes. im glad im getting rid of this and getting a better stable co.

    • every business needs to have alternate and back up plans ...
      I'm sure that BMY does 2, I don't think that they will '
      be stripped, they've got enough cash flow to maintain for
      awhile ... g

    • thank you much Luke , without the knowledge that I'd like
      to have, I would say that BMY wins on this deal and as
      such , I'll hold ...

    • I agree on all counts.

      GLTU

    • It is quite possible that BMY has a succeed of go out of business (merger) strategy.

      If they can license enough new drugs, they can remain independent.

      If not, they are stripped for sale.

    • That's a good point on the savings of the reduced amount of shares they pay on the dividend. Good for BMY shareholders if you keep it.
      From BMY perspective, I'm sure that weighed in the decision, though I think the bottom line is they want to be a drug/bio company.
      All said and from what I can tell, I'm thinking the best move is to hold on to my BMY and let MJN do their own thing. I very well may be wrong and like Just think there is more upside potential and like garce said, there's something to be learned here.

    • garce:

      For BMY it's tax avoidence and a buy back of shares thru the exchange.

      Lets assume that years ago they bought Mead for 1 bil $ and it's now worth 8 bil $. That's a 7 bil taxable capital gain. The same thing would exist if they sold it to another company. By doing the swap they avoid the tax and gain back, 170,000,000 shares of BMY that today are worth approx. 4.1 bil $ and which reduces the div pay out by 211 mil$/yr.

      How the ARBs/hedge funds play this will be interesting to see as in my opinion it's not an easy profitible hedge.

      JMHO

    • I think that he/she did just that ...

      this thing is murky to me, I decided to just watch and
      learn , because someday, I will own some other company that
      will structure a similar deal. There is some reason WHY this
      deal is structured this way ,it should be assumed that somebody
      benefits, I need to learn, so that I can lever the next opp.
      garce

    • For every $1.00 of BMY stock you exchange, you get up to $1.11 of MJN stock, so an instantaneous 11% yield isn't bad. The BMY dividend rate is 4.9% while the PE ratio is about 13. For MJN, PE ratio is 21.7 while dividend yield is 1.82%. MJN competes primarily in infant formulas around the world. My take is if you are going to take your money out of the stock market in the next 12 months, try to exchange BMY for MJN to capialize on the 11% premium. If you will be in longer, the BMY PE ratio and dividend rate seem to be calling.

    • who knows ??? this is quite and advance move and pretty
      limited to the real pros , who don't visit message boards
      to help us .....

      I'm hoping that I can learn from this experience because
      I will probably see others sometime in the future .

      MJN has lots of room to grow and a small understanding number
      of shares. They are in a very mature part of pharma business
      and that sector of pharma will evolve to a near commodity
      status. The real growth is in discovering new drugs that
      will have some minimum number of people who need it.
      Concurring cancer , for one, represents an area of huge
      growth potential. MJN appears to be similar to a company
      called Frontier(telecom) .. Frontier has a large, old ,
      landline business and is buying a huge chunk of landlines
      from VZ .. VZ will continue to do battle in the wireless
      and fiber cable arenas, big risks, big rewards, BMY is
      following the same route,as are other drug companies and
      the field of the more mundane will eventually consolidate to
      a few players and they will do well ...... MJN could be
      a good bet, BMY is still a few years away from realizing
      big returns from bio/onco sectors,which is why the Mederex
      deal was so large ... they will have cash flow and a
      pipeline to help bridge the transition , but which company
      to stay with or buy into ???? only time will tell, but
      it could be a very good strategy to hold both as they
      are apples and oranges to each other ... later ... garce

    • View More Messages
 
BMY
59.30-1.78(-2.91%)2:42 PMEST